- Email: [email protected]
4719149 Method for priming hard tissue
292
PATENT ABSTRACTS
sufficient to selectively dissolve the nucleus pulposus of said disc. Pharmaceutical compositions are also provided for said method which include a purified proteolytically active lyophilized chymopapain, essentially free of proteolytically inactive and toxic components, and an activating amount of a pharmaceutically acceptable reducing agent.
control the capsule wall disintegration speed and its opacity. In addition, inclusion of gas bubbles into the capsule wall lowers the gelatin content for a foam capsule and provides energy saving during the process due to a faster drying of the wall, thereby providing lower cost prices for the production of pharmaceutically acceptable capsules.
4719109
4719149
EM5596-AN ANTIBIOTIC Donald R Kirsch, Edward Meyers, Joseph E Biskupiak assigned to E R Squibb & Sons Inc A novel antibiotic substance EM5596 is prepared by cultivation of a strain of the microorganism Micrococcus luteus A.T.C.C. No. 53598.
4719111 NOVEL COMPOSITION FOR TREATMENT OF DECUBITUS ULCERS Lynn Wilson A composition for treatment of decubitus ulcers comprising an admixture of from about 10 to about 50 parts lecithin, from about 10 to about 50 parts goldenseal root or rhizome, and from about 10 to about 50 parts myrrh gum.
4719112 FOAM CAPSULES
METHOD
FOR PRIMING TISSUE
HARD
Steven M Aasen, Joel Oxman assigned to Minnesota Mining and Manufacturing Company An acid and a water-soluble film former are used as a primer for hard tissue (e.g., dentin). The acid has a pKa less than or equal to that of phenol and the acid and its calcium salt(s) are soluble in the film former. The primer is free of adhesively detrimental quantities of calcium salts that are not soluble in the film former.
4719199 DIURETIC COMPOSITIONS AND METHODS OF PRODUCING DIURESIS Nelson C Yim assigned to Smithkline Beckman Corporation 2- or 3- beta-Indolylalanyl and betaindolylglycyl vasopressins are prepared bystandard peptide synthetic methods. These 2- or 3TRP vasopressins have vasopressin antagonist activity.
Jean Mayer, Frit Wittwer, Colmar, France assigned to Warner-Lambert Company
4719200
Foam capsules with telescopically engaged body and cap portions, also known as hard shell capsules, having a special wall structure, obtained by a microdispersion of a gas in a gelatin solution. The capsule body and cap portions are formed by dipmolding the film-forming mixture obtained by a microdispersion of the gas in a gelatin solution; optionally with the inclusion of a plasticizer and/or coloring agent, and/or flavoring agent, and/or foam stabilizer, and/or gelatin extender. By a suitable choice of the gas proportion in the capsule wall and its micronization level, it is possible, within certain limits, to
AMINO ACID DERIVATIVES AND ANTIHYPERTENSIVE DRUGS CONTAINING THE SAME Chikahiko Eguchi, Masahiko Kurauchi, Shumpei Sakakibara, Yokohama, Japan assigned to Ajinomoto Co Inc An amino acid derivative having antihypertensive activity and having the formula: See Patentfor Chemical Structure wherein one of X or Y represents an acyl group RCO-, and wherein R is an amino acid residue selected from
PATENT ABSTRACTS
sufficient to selectively dissolve the nucleus pulposus of said disc. Pharmaceutical compositions are also provided for said method which include a purified proteolytically active lyophilized chymopapain, essentially free of proteolytically inactive and toxic components, and an activating amount of a pharmaceutically acceptable reducing agent.
control the capsule wall disintegration speed and its opacity. In addition, inclusion of gas bubbles into the capsule wall lowers the gelatin content for a foam capsule and provides energy saving during the process due to a faster drying of the wall, thereby providing lower cost prices for the production of pharmaceutically acceptable capsules.
4719109
4719149
EM5596-AN ANTIBIOTIC Donald R Kirsch, Edward Meyers, Joseph E Biskupiak assigned to E R Squibb & Sons Inc A novel antibiotic substance EM5596 is prepared by cultivation of a strain of the microorganism Micrococcus luteus A.T.C.C. No. 53598.
4719111 NOVEL COMPOSITION FOR TREATMENT OF DECUBITUS ULCERS Lynn Wilson A composition for treatment of decubitus ulcers comprising an admixture of from about 10 to about 50 parts lecithin, from about 10 to about 50 parts goldenseal root or rhizome, and from about 10 to about 50 parts myrrh gum.
4719112 FOAM CAPSULES
METHOD
FOR PRIMING TISSUE
HARD
Steven M Aasen, Joel Oxman assigned to Minnesota Mining and Manufacturing Company An acid and a water-soluble film former are used as a primer for hard tissue (e.g., dentin). The acid has a pKa less than or equal to that of phenol and the acid and its calcium salt(s) are soluble in the film former. The primer is free of adhesively detrimental quantities of calcium salts that are not soluble in the film former.
4719199 DIURETIC COMPOSITIONS AND METHODS OF PRODUCING DIURESIS Nelson C Yim assigned to Smithkline Beckman Corporation 2- or 3- beta-Indolylalanyl and betaindolylglycyl vasopressins are prepared bystandard peptide synthetic methods. These 2- or 3TRP vasopressins have vasopressin antagonist activity.
Jean Mayer, Frit Wittwer, Colmar, France assigned to Warner-Lambert Company
4719200
Foam capsules with telescopically engaged body and cap portions, also known as hard shell capsules, having a special wall structure, obtained by a microdispersion of a gas in a gelatin solution. The capsule body and cap portions are formed by dipmolding the film-forming mixture obtained by a microdispersion of the gas in a gelatin solution; optionally with the inclusion of a plasticizer and/or coloring agent, and/or flavoring agent, and/or foam stabilizer, and/or gelatin extender. By a suitable choice of the gas proportion in the capsule wall and its micronization level, it is possible, within certain limits, to
AMINO ACID DERIVATIVES AND ANTIHYPERTENSIVE DRUGS CONTAINING THE SAME Chikahiko Eguchi, Masahiko Kurauchi, Shumpei Sakakibara, Yokohama, Japan assigned to Ajinomoto Co Inc An amino acid derivative having antihypertensive activity and having the formula: See Patentfor Chemical Structure wherein one of X or Y represents an acyl group RCO-, and wherein R is an amino acid residue selected from